Peripheral blood Th9 cells and eosinophil apoptosis in asthma patients

Medicina (Lithuania)

Volumn 51, Issue 1, 2015, Pages 10-17

  Hoppenot, Deimante ^a   Malakauskas, Kestutis ^a   Lavinskiene, Simona ^a   Bajoriuniene, Ieva ^a   Kalinauskaite, Virginija ^a   Sakalauskas, Raimundas ^a  

^a LITHUANIAN UNIVERSITY OF HEALTH SCIENCES   (Lithuania)

Author keywords

Allergic asthma; Eosinophil apoptosis; Interleukin 5; Interleukin 9; Th9 cells

Indexed keywords

IL5 PROTEIN, HUMAN; IL9 PROTEIN, HUMAN; INTERLEUKIN 5; INTERLEUKIN 9;

ADULT; APOPTOSIS; ASTHMA; BLOOD; CD4+ T LYMPHOCYTE; EOSINOPHIL; FEMALE; FLOW CYTOMETRY; HELPER CELL; HUMAN; IMMUNOLOGY; LYMPHOCYTE COUNT; MALE; PERENNIAL RHINITIS; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADULT; APOPTOSIS; ASTHMA; CD4-POSITIVE T-LYMPHOCYTES; EOSINOPHILS; FEMALE; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-5; INTERLEUKIN-9; LYMPHOCYTE COUNT; MALE; RHINITIS, ALLERGIC, PERENNIAL; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; YOUNG ADULT;

EID: 84951965683     PISSN: 1010660X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medici.2015.01.001     Document Type: Article

References (30)

1. Global initiative for asthma (GINA) Global strategy for asthma management and prevention: NHLBI/WHO workshop report 2002, National Institutes of Health, National Heart, Lung and Blood Institute, Bethesda, Revised 2012. Available from: http://www.ginasthma.org/.
2. Alcorn J.F., Crowe C.R., Kolls J.K. TH17 cells in asthma and COPD. Annu Rev Physiol 2010, 72:495-516.
3. Veldhoen M., Uyttenhove C., van Snick J., Helmby H., Westendorf A., Buer J., et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 2008, 9(12):1341-1346.
4. Dardalhon V., Awasthi A., Kwon H., Galileos G., Gao W., Sobel R.A., et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nat Immunol 2008, 9(12):1347-1355.
5. Putheti P., Awasthi A., Popoola J., Gao W., Strom T.B. Human CD4 memory T cells can become CD4+IL-9+ T cells. PLoS ONE 2010, 5(1):e8706.
6. Temann U.A., Ray P., Flavell R.A. Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology. J Clin Investig 2002, 109(1):29-39.
7. Kearley J., Erjefalt J.S., Andersson C., Benjamin E., Jones C.P., Robichaud A., et al. IL-9 governs allergen-induced mast cell numbers in the lung and chronic remodeling of the airways. Am J Respir Crit Care Med 2011, 183(7):865-875.
8. Erpenbeck V.J., Hohlfeld J.M., Discher M., Krentel H., Hagenberg A., Braun A., et al. Increased expression of interleukin-9 messenger RNA after segmental allergen challenge in allergic asthmatics. Chest 2003, 123(Suppl. 3):370S.
9. White B., Leon F., White W., Robbie G. Two first-in-human, open-label, phase I dose-escalation safety trials of MEDI-528, a monoclonal antibody against interleukin-9, in healthy adult volunteers. Clin Therap 2009, 31(4):728-740.
10. Vermeer P.D., Harson R., Einwalter L.A., Moninger T., Zabner J. Interleukin-9 induces goblet cell hyperplasia during repair of human airway epithelia. Am J Respir Cell Mol Biol 2003, 28(3):286-295.
11. Townsend J.M., Fallon G.P., Matthews J.D., Smith P., Jolin E.H., McKenzie N.A. IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. Immunity 2000, 13(4):573-583.
12. Cho J.Y., Miller M., Baek K.J., Han J.W., Nayar J., Lee S.Y., et al. Inhibition of airway remodeling in IL-5-deficient mice. J Clin Invest 2004, 113(4):551-560.
13. Rothenberg M.E., Hogan S.P. The eosinophil. Annu Rev Immunol 2006, 24:147-174.
14. Gounni A.S., Gregory B., Nutku E., Aris F., Latifa K., Minshall E., et al. Interleukin-9 enhances interleukin-5 receptor expression, differentiation, and survival of human eosinophils. Blood 2000, 96(6):2163-2171.
15. Simon H.U. Cell death in allergic diseases. Apoptosis 2009, 14(4):439-446.
16. Bousquet J., Khaltaev N., Cruz A.A., Denburg J., Fokkens W.J., Togias A., et al. Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization GA(2)LEN and AllerGen). Allergy 2008, 63(Suppl. 86):8-160.
17. Dreborg S. The skin prick test in the diagnosis of atopic allergy. J Am Acad Dermatol 1989, 21(4 (Pt. 2)):820-821.
18. Pellegrino R., Viegi G., Brusasco V., Crapo R.O., Burgos F., Casaburi R., et al. Interpretative strategies for lung function tests. Eur Respir J 2005, 26(5):948-968.
19. Baur X., Huber H., Degens P.O., Allmers H., Ammon J. Relation between occupational asthma case history, bronchial methacholine challenge, and specific challenge test in patients with suspected occupational asthma. Am J Ind Med 1998, 33(2):114-122.
20. Jabeen R., Kaplan M.H. The symphony of the ninth: the development and function of Th9 cells. Curr Opin Immunol 2012, 24(3):303-307.
21. Chang H.C., Sehra S., Goswami R., Yao W., Yu Q., Stritesky G.L., et al. The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 2010, 11(6):527-534.
22. Jones C.P., Gregory L.G., Causton B., Campbell G.A., Lloyd C.M. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J Allergy Clin Immunol 2012, 129(4). 1000-10.e3.
23. Kerzerho J., Maazi H., Speak A.O., Szely N., Lombardi V., Khoo B., et al. Programmed cell death ligand 2 regulates TH9 differentiation and induction of chronic airway hyperreactivity. J Allergy Clin Immunol 2013, 131(4):1048-1057. 1057.e1-e2.
24. Temann U.A., Geba G.P., Rankin J.A., Flavell R.A. Expression of interleukin 9 in the lungs of transgenic mice causes airway inflammation, mast cell hyperplasia, and bronchial hyperresponsiveness. J Exp Med 1998, 188(7):1307-1320.
25. Cheng G., Arima M., Honda K., Hirata H., Eda F., Yoshida N., et al. Anti-interleukin-9 antibody treatment inhibits airway inflammation and hyperreactivity in mouse asthma model. Am J Respir Crit Care Med 2002, 166(3):409-416.
26. Shimbara A., Christodoulopoulos P., Soussi-Gounni A., Olivenstein R., Nakamura Y., Levitt R.C., et al. IL-9 and its receptor in allergic and nonallergic lung disease: increased expression in asthma. J Allergy Clin Immunol 2000, 105(1 (Pt 1)):108-115.
27. Dong Q., Louahed J., Vink A., Sullivan C.D., Messler C.J., Zhou Y., et al. IL-9 induces chemokine expression in lung epithelial cells and baseline airway eosinophilia in transgenic mice. Eur J Immunol 1999, 29(7):2130-2139.
28. Vignola A.M., Chanez P., Chiappara G., Siena L., Merendino A., Reina C., et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol 1999, 103(4):563-573.
29. Kodama T., Matsuyama T., Miyata S., Nishimura H., Nishioka Y., Kitada O., et al. Kinetics of apoptosis in the lung of mice with allergic airway inflammation. Clin Exp Allergy: J Br Soc Allergy Clin Immunol 1998, 28(11):1435-1443.
30. Levitt R.C., McLane M.P., MacDonald D., Ferrante V., Weiss C., Zhou T., et al. IL-9 pathway in asthma: new therapeutic targets for allergic inflammatory disorders. J Allergy Clin Immunol 1999, 103(5 (Pt. 2)):S485-S491.